-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Data show that in 2020, there will be more than 110,000 new cases of prostate cancer in China, and more than 50,000 deaths.
Why is prostate cancer so high? How can we find out early? What are the main treatment methods? Recently, Sina Medicine interviewed Professor Gong Kan, chief physician of the Department of Urology, Peking University First Hospital, on the above issues, so that the public can understand this "silent killer" more comprehensively
Early symptoms are hidden, high-risk groups need to be screened
Early symptoms are hidden, high-risk groups need to be screenedThere are many reasons behind the high incidence of prostate cancer in China
In addition to high morbidity, prostate cancer in China also presents the characteristics of high mortality.
So, how can the signs of disease be detected early? According to Professor Gong Kan, there are no specific symptoms in the early stage of prostate cancer.
In this regard, Professor Gong Kan suggested that men over the age of 50 should undergo PSA examinations every year.
At present, the normal value of PSA used in China is 4ng/mL.
Therefore, in addition to PSA testing, it can also be combined with digital rectal examination (DRE), imaging examination, and prostate biopsy for comprehensive judgment
Adhere to standardized treatment to improve the quality of life of patients
Adhere to standardized treatment to improve the quality of life of patientsIf prostate cancer is diagnosed, clinicians will adopt corresponding treatment plans according to different stages
Early-stage patients do not need to rush for treatment, because prostate cancer is an indolent disease, progressing relatively slowly, and compared with cancer types such as liver cancer and pancreatic cancer, it has a lower degree of malignancy
At present, most patients in China are in the late stage, locally late stage or distant metastasis stage at the first diagnosis, and a comprehensive treatment plan is needed
At the same time, Professor Gong Kan also said, “Tumor is a disease that requires comprehensive treatment.
What Professor Gong Kan introduced is the much-concerned Multi-Disciplinary Treatment (MDT) model.
In addition, China has a vast territory and a large gap in medical standards between regions.
